Monitoring Minimal Residual Disease in the Myeloproliferative Neoplasms: Current Applications and Emerging Approaches

Approaches such as digital PCR have demonstrated improved, assay characteristics and are likely to play an increasing role in the monitoring of myeloproliferative neoplasms. While next-generation sequencing is increasingly valuable as a tool for the diagnosis of myeloproliferative neoplasms, its role in the assessment of minimal residual disease requires further evaluation.

 Biomed Res Int

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.